Abstract

We investigated and compared the robustness of supercritical fluid chromatography (SFC) separations of the peptide gramicidin, using either isocratic or gradient elution. This was done using design of experiments in a design space of co-solvent fraction, water mass fraction in co-solvent, pressure, and temperature. The density of the eluent (CO2-MeOH-H2O) was experimentally determined using a Coriolis mass flow meter to calculate the volumetric flow rate required by the design. For both retention models, the most important factor was the total co-solvent fraction and water mass fraction in co-solvent. Comparing the elution modes, we found that gradient elution was more than three times more robust than isocratic elution. We also observed a relationship between the sensitivity to changes and the gradient steepness and used this to draw general conclusions beyond the studied experimental system.To test the robustness in a practical context, both the isocratic and gradient separations were transferred to another laboratory. The gradient elution was highly reproducible between laboratories, whereas the isocratic system was not. Using measurements of the actual operational conditions (not the set system conditions), the isocratic deviation was quantitatively explained using the retention model. The findings indicate the benefits of using gradient elution in SFC as well as the importance of measuring the actual operational conditions to be able to explain observed differences between laboratories when conducting method transfer.

Highlights

  • The separation of therapeutic peptides has long been an important application area for chromatography, reversed-phase liquid chromatography (RPLC) [1]

  • The small but growing body of studies treating the supercritical fluid chromatography (SFC) separation of peptides [4,5,6,7,8,9,10,11,12,13] has investigated a limited number of peptides, for example, gramicidin D [6,12,13], leucineenkephalin [4,5,6,10], methionine-enkephalin [4,5,6,10], angiotensin I [4], angiotensin in detail (II) [4,5,6], cyclosporin analogs [7], betamethylphenylalanine [11], oxytocin [10], bradykinin [4,10], Pro-Leu-Gly amide [4], sauvagine [4], leupeptide [4], urotensin II [4], sulfomycin [8], cyclic peptides [16], and custom acidic and basic linear uncapped peptides [9]

  • We studied the linear uncharged pentapeptide gramicidin separated on a pH-stable hybrid silica column using an eluent containing CO2, water, and methanol

Read more

Summary

Introduction

The separation of therapeutic peptides has long been an important application area for chromatography, reversed-phase liquid chromatography (RPLC) [1]. The small but growing body of studies treating the SFC separation of peptides [4,5,6,7,8,9,10,11,12,13] has investigated a limited number of peptides, for example, gramicidin D [6,12,13], leucineenkephalin [4,5,6,10], methionine-enkephalin [4,5,6,10], angiotensin I [4], angiotensin II [4,5,6], cyclosporin analogs [7], betamethylphenylalanine [11], oxytocin [10], bradykinin [4,10], Pro-Leu-Gly amide [4], sauvagine [4], leupeptide [4], urotensin II [4], sulfomycin [8], cyclic peptides [16], and custom acidic and basic linear uncapped peptides [9].

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call